🔎 Trials Near Me

መነሻ › ዲፕሬሽን › አላባማ

በአላባማ ለዲፕሬሽን የሚደረጉ ክሊኒካዊ ጥናቶች

ለዲፕሬሽን የሚደረጉ 15 ጥናቶች በአላባማ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በአላባማ ውስጥ ያሉ ከተሞች

Official study text (English)

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  • University of Alabama at Birmingham - School of Medicine, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07775300

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • UAB Psychiatry and Behavioral Neurology, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06793397

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • UAB, Psychiatry and Behavioral Neurology, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT07002034

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • University of Alabama at Birmingham, Huntsville Regional Medical Campus, Huntsville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 74 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07076407

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

  • Birmingham VA Medical Center, Birmingham, AL, Birmingham
  • Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT07226232

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Huntsville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT06911112

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Huntsville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT06966401

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Campus, Huntsville
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ10 እስከ 24 · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05437588

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Center, Huntsville
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁን 2026 · NCT03887715

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

  • University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኤፕሪ 2026 · NCT05927974

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

  • University of South Alabama, Mobile
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ19 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኤፕሪ 2026 · NCT06467695

MicroRNA Correlates of Childhood Maltreatment and Suicidality

  • University of Alabama at Birmingham, Birmingham
  • UAB Huntsville Regional Medical Campus, Huntsville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ30 ማርች 2026 · NCT04923685

Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

  • University of Alabama Birmingham Hospital, Birmingham
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ12 እስከ 22 · ሁሉም ጾታዎች · የተሻሻለው በ30 ኦክቶ 2025 · NCT06232304

Digital Intervention for Physical Activity

  • Kinesiology Building, Auburn
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ19 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2025 · NCT07130734

Strengthening Health and Insight in New Educators

  • University of Alabama, Tuscaloosa
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኤፕሪ 2025 · NCT06745934

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።